Hubei Goto Biopharm Co.,Ltd.
SZSE:300966.SZ
21.06 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||||
| Net Income
| 1.082 | 0 | -9.044 | -8.666 | 3.547 | 0.221 | 5.312 | 13.448 | 4.024 | 0.288 | 12.937 | 13.936 | 13.044 | 24.265 | 13.022 | 25.766 | 15.277 | 21.998 | 12.608 | 20.885 | -2.203 | 0 |
| Depreciation & Amortization
| 0 | 0 | 0 | 7.827 | 7.827 | 28.207 | -14.523 | 7.964 | 7.964 | 28.042 | 7.56 | 6.461 | 6.461 | 6.065 | 6.065 | 5.614 | 5.614 | 21.183 | -10.469 | 10.469 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | -21.985 | 36.508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 1.407 | 0 | 1.689 | -1.376 | 1.376 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | 9.664 | 0 | -68.67 | 37.883 | -37.883 | 0 | -95.083 | 62.331 | -62.331 | 0 | -153.099 | 53.099 | -53.099 | 0 | -23.294 | -21.264 | 21.264 | 0 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 1.661 | 0 | -60.595 | 15.7 | -15.7 | 0 | -34.655 | 15.903 | -15.903 | 0 | 20.234 | 5.905 | -5.905 | 0 | -66.3 | 11.48 | -11.48 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 6.596 | 0 | -9.764 | 23.559 | -23.559 | 0 | -60.428 | 46.428 | -46.428 | 0 | -173.334 | 47.194 | -47.194 | 0 | 43.006 | -32.743 | 32.743 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 1.407 | 0 | 1.689 | -1.376 | 1.376 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -29.856 | -113.865 | 68.205 | 74.829 | -27.769 | 98.972 | 43.507 | -3.424 | -69.383 | 42.554 | -69.302 | 65.13 | -43.143 | 38.576 | -11.66 | -28.131 | 4.245 | -20.486 | 15.124 | -16.723 | -15.618 | 0 |
| Operating Cash Flow
| -28.774 | -113.865 | 59.162 | 58.337 | -24.222 | 58.729 | 48.82 | 17.987 | -57.395 | -24.199 | 13.526 | 23.197 | -36.56 | 56.777 | -4.703 | -7.979 | 13.908 | -0.598 | -4 | 35.894 | -17.821 | 0 |
| Investing Activities: | ||||||||||||||||||||||
| Investments In Property Plant And Equipment
| -82.26 | 17.34 | -151.602 | -119.122 | -58.231 | -83.803 | -112.362 | -79.884 | -133.205 | -77.461 | -203.173 | -76.092 | -51.214 | -27.511 | -20.463 | -40.656 | -2.246 | -7.061 | -4.388 | -3.589 | -3.529 | 0 |
| Acquisitions Net
| 0.133 | 0 | 0 | 0.005 | 0.099 | 19.6 | 0 | -0.023 | 0.023 | 0 | 0.134 | 13.2 | 16.2 | 16.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.023 | -0.023 | 0 | -19.2 | -13.302 | -14.4 | 2 | -2 | -14.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.009 | 15.018 | 0 | 0 | 0.102 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 17.172 | 24.5 | 0.005 | 0.099 | -8.124 | 20 | 24.998 | -29.977 | -14.982 | -0.018 | 0.102 | -14.4 | -0.037 | -0.1 | -14.5 | -2.246 | -7.057 | -4.324 | -0.02 | -3.529 | 14.214 |
| Investing Cash Flow
| -82.126 | 34.512 | -127.101 | -119.117 | -58.132 | -91.926 | -92.362 | -69.896 | -148.163 | -92.443 | -222.258 | -75.99 | -65.614 | -25.548 | -22.463 | -55.156 | -2.246 | -7.057 | -4.324 | -3.609 | -3.529 | 14.214 |
| Financing Activities: | ||||||||||||||||||||||
| Debt Repayment
| 90.911 | 80.321 | -70.498 | 231.19 | 48.38 | 10.686 | 0 | -33.48 | 15.378 | 304.736 | 9.636 | 287.865 | 100.886 | 15.978 | -21.486 | 6.27 | 2.473 | 0 | 0 | -24.207 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.978 | 11.451 | -11.451 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32.4 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | -5.4 | 0 | 0 | 0 |
| Dividends Paid
| 0 | -12.675 | -4.801 | -5.122 | -3.095 | -4.56 | -2.889 | -0.513 | -8.278 | -2.794 | -1.531 | -19.48 | -3.102 | -1.802 | -2.456 | -1.679 | -1.639 | -1.895 | -2.119 | -2.59 | -2.56 | 0 |
| Other Financing Activities
| 5.112 | 31.874 | -0 | 23.829 | -0 | 19.623 | 9.93 | 0.826 | -0.25 | 50.786 | -11.124 | 14.717 | -1.099 | -1.571 | 0.475 | 196.118 | 0 | -19.717 | -2.706 | 5.4 | 15.937 | -22.905 |
| Financing Cash Flow
| 96.023 | 99.521 | -75.299 | 249.897 | 45.285 | 34.869 | 7.04 | -33.167 | 6.85 | 320.328 | -3.018 | 283.102 | 112.884 | 28.925 | -23.467 | 200.709 | 0.834 | -19.717 | -2.706 | -21.397 | 13.377 | -22.905 |
| Other Information: | ||||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -1.665 | 0.103 | 0.729 | 0.271 | -0.237 | 0.138 | -0.241 | 0.019 | -0.096 | 0.317 | 0.094 | -0.037 | -0.054 | -0.05 | -0.312 | -0.021 | 0.224 | -0.138 | -0.012 | -0.009 | 0 |
| Net Change In Cash
| 0 | 18.504 | -167.636 | 187.507 | -36.798 | 1.435 | -36.364 | -85.325 | -198.689 | 203.589 | -211.432 | 230.403 | 10.673 | 60.1 | -50.683 | 137.263 | 12.475 | -76.683 | -68.106 | 10.876 | -7.981 | -8.691 |
| Cash At End Of Period
| 157.141 | 100.122 | 81.618 | 304.3 | 59.425 | 96.206 | 94.771 | 131.135 | 216.46 | 415.15 | 211.561 | 422.993 | 192.59 | 181.917 | 121.816 | 172.499 | 35.236 | -26.774 | -7.029 | 61.076 | 50.201 | -8.691 |